Staining of tumour fragments using haematoxylin and eosin (Supplementary Fig. 1) or Ki67 (Supplementary Fig. 2) confirmed the heterogenous nature of GBM at a cellular level regarding density, morphology, and proliferative potential. This evidence concerns the gene MKI67 and glioblastoma.